MIM
GLSI icon

MetLife Investment Management’s Greenwich LifeSciences GLSI Stock Holding History

MetLife Investment Management’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$91.6K Buy
+3,814
New +$99.5K ﹤0.01% 2576

Other funds holding GLSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

MetLife Investment Management's GLSI Position: Q1 2026 in Review

MetLife Investment Management opened a new position in Greenwich LifeSciences (GLSI) in Q1 2026: 3,814 shares worth $91.6K. The stake represents ﹤0.01% of the portfolio and ranks #2576 among its holdings.

64 funds tracked by Wall St. Rank hold GLSI as of Q1 2026.

  • MetLife Investment Management held 3,814 shares of Greenwich LifeSciences worth $91.6K as of Q1 2026.
  • Greenwich LifeSciences was a new MetLife Investment Management position in Q1 2026.
  • Greenwich LifeSciences made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2576 holding.
  • 64 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.